WO2020055193A1 - Micro-organisme à activité antibactérienne pour des bactéries pathogènes entériques et composition pharmaceutique pour la prévention et le traitement d'une maladie induite par des bactéries pathogènes entériques utilisant celui-ci - Google Patents

Micro-organisme à activité antibactérienne pour des bactéries pathogènes entériques et composition pharmaceutique pour la prévention et le traitement d'une maladie induite par des bactéries pathogènes entériques utilisant celui-ci Download PDF

Info

Publication number
WO2020055193A1
WO2020055193A1 PCT/KR2019/011879 KR2019011879W WO2020055193A1 WO 2020055193 A1 WO2020055193 A1 WO 2020055193A1 KR 2019011879 W KR2019011879 W KR 2019011879W WO 2020055193 A1 WO2020055193 A1 WO 2020055193A1
Authority
WO
WIPO (PCT)
Prior art keywords
microorganism
pathogenic bacteria
acid
pharmaceutical composition
enteric
Prior art date
Application number
PCT/KR2019/011879
Other languages
English (en)
Other versions
WO2020055193A9 (fr
Inventor
Sang Sun Yoon
Mi Young Yoon
Jin Sun You
Original Assignee
Industry-Academic Cooperation Foundation, Yonsei University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Industry-Academic Cooperation Foundation, Yonsei University filed Critical Industry-Academic Cooperation Foundation, Yonsei University
Publication of WO2020055193A1 publication Critical patent/WO2020055193A1/fr
Publication of WO2020055193A9 publication Critical patent/WO2020055193A9/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne une composition pharmaceutique pour la prévention ou le traitement de maladies induites par des bactéries pathogènes entériques et une composition d'aliment pour l'amélioration d'une infection entérique par des bactéries pathogènes entériques, comprenant un micro-organisme Bacteroides vulgatus à activité antibactérienne pour des bactéries pathogènes entériques ou un milieu de culture de celui-ci, en tant que principe actif.
PCT/KR2019/011879 2018-09-14 2019-09-11 Micro-organisme à activité antibactérienne pour des bactéries pathogènes entériques et composition pharmaceutique pour la prévention et le traitement d'une maladie induite par des bactéries pathogènes entériques utilisant celui-ci WO2020055193A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20180110258 2018-09-14
KR10-2018-0110258 2018-09-14

Publications (2)

Publication Number Publication Date
WO2020055193A1 true WO2020055193A1 (fr) 2020-03-19
WO2020055193A9 WO2020055193A9 (fr) 2020-07-30

Family

ID=69776711

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2019/011879 WO2020055193A1 (fr) 2018-09-14 2019-09-11 Micro-organisme à activité antibactérienne pour des bactéries pathogènes entériques et composition pharmaceutique pour la prévention et le traitement d'une maladie induite par des bactéries pathogènes entériques utilisant celui-ci

Country Status (2)

Country Link
KR (2) KR102269450B1 (fr)
WO (1) WO2020055193A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102269450B1 (ko) * 2018-09-14 2021-06-25 연세대학교 산학협력단 장내 병원성 세균에 대한 항균 활성 균주 및 이를 포함하는 병원성 장내 세균 유발성 질환의 예방 또는 치료용 약학적 조성물

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016049827A1 (fr) * 2014-09-30 2016-04-07 Bgi Shenzhen Co., Limited Utilisation de bactéroïdes dans la prévention et le traitement d'une coronaropathie
WO2016209806A1 (fr) * 2015-06-22 2016-12-29 President And Fellows Of Harvard College Induction de lymphocytes t régulateurs lamina propria
JP2018502551A (ja) * 2015-06-15 2018-02-01 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 細菌株を含む組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3628161T3 (da) * 2012-11-23 2023-05-30 Seres Therapeutics Inc Synergistiske bakterielle sammensætninger og fremgangsmåder til fremstilling og anvendelse deraf
KR102269450B1 (ko) * 2018-09-14 2021-06-25 연세대학교 산학협력단 장내 병원성 세균에 대한 항균 활성 균주 및 이를 포함하는 병원성 장내 세균 유발성 질환의 예방 또는 치료용 약학적 조성물

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016049827A1 (fr) * 2014-09-30 2016-04-07 Bgi Shenzhen Co., Limited Utilisation de bactéroïdes dans la prévention et le traitement d'une coronaropathie
JP2018502551A (ja) * 2015-06-15 2018-02-01 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 細菌株を含む組成物
WO2016209806A1 (fr) * 2015-06-22 2016-12-29 President And Fellows Of Harvard College Induction de lymphocytes t régulateurs lamina propria

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HSIAO, A. ET AL.: "Members of the human gut microbiota involved in recovery from Vibrio cholerae infection", NATURE, vol. 515, no. 7527, 20 November 2014 (2014-11-20), pages 423 - 426, XP055693611 *
MIDANI, F. S. ET AL.: "Human gut microbiota predicts susceptibility to Vibrio cholerae infection", THE JOURNAL OF INFECTIOUS DISEASES, vol. 218, no. 4, 12 April 2018 (2018-04-12), pages 645 - 653, XP055693623 *
YOON, M. Y. ET AL.: "A single gene of a commensal microbe affects host susceptibility to enteric infection", NATURE COMMUNICATIONS, vol. 7, no. 1, 13 May 2016 (2016-05-13), pages 11606, XP055693619 *
YOON, S. S.: "Commensal-derived metabolites govern Vibrio cholera pathogenesis in host intestine", THE 27TH FEDERATION MEETING OF KOREAN BASIC MEDICAL SCIENTISTS 2019, 28 June 2019 (2019-06-28) *

Also Published As

Publication number Publication date
KR102269450B1 (ko) 2021-06-25
KR20200031543A (ko) 2020-03-24
KR102363357B1 (ko) 2022-02-15
KR20210080303A (ko) 2021-06-30
WO2020055193A9 (fr) 2020-07-30

Similar Documents

Publication Publication Date Title
Khan et al. The gut microbiota of laying hens and its manipulation with prebiotics and probiotics to enhance gut health and food safety
CN108603162B (zh) 预防、改善或治疗退行性脑病或认知功能障碍的新型乳酸菌和组合物
Sonnenborn et al. The non-pathogenic Escherichia coli strain Nissle 1917–features of a versatile probiotic
RU2412241C2 (ru) Способ профилактики желудочно- кишечных заболеваний у животных или людей, способ лечения желудочно-кишечных заболеваний у животных или людей и лекарственное средство для лечения или профилактики желудочно-кишечных заболеваний у животных или людей
Tsabouri et al. Modulation of gut microbiota downregulates the development of food allergy in infancy
WO2016153247A1 (fr) Souche de clostridium butyricum présentant une amélioration immunitaire et activités antivirales, et utilisation correspondante
Bodhidatta et al. Bacterial pathogens isolated from raw meat and poultry compared with pathogens isolated from children in the same area of rural Thailand
WO2017047962A1 (fr) Nouveau lactobacillus et composition pour prévenir, atténuer ou traiter des maladies cérébrales dégénératives ou des troubles de la fonction cognitive
WO2019088379A1 (fr) Nouvelles bactéries lactiques et leur utilisation
WO2020055193A1 (fr) Micro-organisme à activité antibactérienne pour des bactéries pathogènes entériques et composition pharmaceutique pour la prévention et le traitement d'une maladie induite par des bactéries pathogènes entériques utilisant celui-ci
WO2022092964A1 (fr) Composition pour la prévention ou le traitement d'une maladie intestinale inflammatoire
WO2021246610A1 (fr) Composition pour la prévention ou le traitement de maladies inflammatoires, comprenant une souche de lactobacillus sakei cvl-001
Fang et al. Yersinia enterocolitica in Crohn’s disease
WO2015088227A1 (fr) Nouvelles bactéries lactiques et composition contenant celles-ci pour la prévention ou le traitement de la diarrhée chez le nourrisson
Gupta et al. Rise of the guardians: Gut microbial maneuvers in bacterial infections
Lee et al. Isolation, characterization, and evaluation of wild isolates of Lactobacillus reuteri from pig feces
WO2023177218A1 (fr) Souche de lacticaseibacillus paracasei ayant une activité inhibitrice de pathogène parodontal, et son utilisation
Ziprin et al. Colonization control of lactose-fermenting Salmonella typhimurium in young broiler chickens by use of dietary lactose
Takahata et al. Evaluation of therapeutic properties of fermented vegetables extract (OM-X®) in the model of colitis induced by Citrobacter rodentium in mice
WO2022231178A1 (fr) Nouvelle souche de lactobacillus fermentum atg-v5, ou composition pour renforcer l'immunité la comprenant
Zheng et al. Eugenol alleviates Salmonella Typhimurium-infected cecal injury by modulating cecal flora and tight junctions accompanied by suppressing inflammation
WO2024080441A1 (fr) Souche de paracoccus aminovorans bm109 et ses utilisations
WO2023287025A1 (fr) Souche de cutibacterium avidum, milieu de culture dérivé de celle-ci, et son utilisation antibactérienne
WO2023200203A1 (fr) Nouveau microorganisme et composition le comprenant
WO2023229104A1 (fr) Composition de complexe probiotique ayant des fonctions immunomodulatrices et d'homéostasie immunitaire

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19860969

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19860969

Country of ref document: EP

Kind code of ref document: A1